Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Invida has acquired India-based Shalaks Pharmaceuticals' dermatology brand portfolio products.
Subscribe to our email newsletter
The acquisition allow the company to commercialize all Shalaks’ products under the Invida brand.
Invida will market Shalaks’ dermatology brands, including topical anti-acne, anti-fungal, anti-scar, anti-pigmentation, sun screens and moisturizers and primary care portfolio comprising seven brands.
Invida CEO John Graham said this product portfolio, combined with their recent addition of products from Sinclair Pharmaceuticals, allows them to target the Indian market with both high-end differentiated and main stream dermatology products.